Trial intelligence / Profile preview

Valdecoxib vs. Diclofenac in Acute Ankle Sprain

NCT00671320Phase 4Completed

Sponsor
Pfizer
Start
Dec 2002
Modality
Small Molecules
Countries
5
01

Overview

Phase 4, randomised, double-blind trial of valdecoxib in Ankle sprain (2 arms), sponsored by Pfizer. Primary endpoint: Patient's assessment of ankle pain VAS at Day 4. Started Dec 2002; status: completed.

02

Drugs

valdecoxib
03

Conditions

Ankle sprain

Beyond the preview

Go deeper on NCT00671320.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00671320.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call